Literature DB >> 33197563

Resveratrol and artemisinin eudragit-coated liposomes: A strategy to tackle intestinal tumors.

Carla Caddeo1, Morena Gabriele2, Amparo Nácher3, Xavier Fernàndez-Busquets4, Donatella Valenti5, Anna Maria Fadda5, Laura Pucci6, Maria Manconi5.   

Abstract

Resveratrol and artemisinin, two naturally occurring compounds with a wide range of biological activities, have been reported to exert antitumor effects against several types of cancer. In this work, Eudragit-coated liposomes were developed to safely transport resveratrol and artemisinin through the gastrointestinal tract and target the intestine. The physico-chemical properties of the Eudragit-coated liposomes were assessed by light scattering and cryogenic transmission electron microscopy. Nanosized (around 100 nm), spherical or elongated, unilamellar vesicles were produced. The protective effect of the Eudragit coating was confirmed by assessing the physical stability of the vesicles in fluids mimicking the gastrointestinal environment. Furthermore, the vesicles were found to exert a pro-oxidant activity in intestinal adenocarcinoma cells, which resulted in a marked mortality due to the generation of reactive oxygen species (ROS). A time- and dose-dependent cell growth inhibitory effect was detected, with elevated ROS levels when resveratrol and artemisinin were combined. Therefore, the proposed formulations may represent a valuable means to counteract intestinal tumor growth.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antitumor; Artemisinin; Eudragit; Intestinal delivery; Liposomes; Resveratrol

Mesh:

Substances:

Year:  2020        PMID: 33197563     DOI: 10.1016/j.ijpharm.2020.120083

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Flavonoids from Selaginella doederleinii Hieron and Their Antioxidant and Antiproliferative Activities.

Authors:  Felix Wambua Muema; Ye Liu; Yongli Zhang; Guilin Chen; Mingquan Guo
Journal:  Antioxidants (Basel)       Date:  2022-06-17

Review 2.  Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy.

Authors:  Zerrin Sezgin-Bayindir; Sonia Losada-Barreiro; Carlos Bravo-Díaz; Matej Sova; Julijana Kristl; Luciano Saso
Journal:  Antioxidants (Basel)       Date:  2021-04-27

3.  AaCycTL Regulates Cuticle and Trichome Development in Arabidopsis and Artemisia annua L.

Authors:  Boran Dong; Xingxing Wang; Rui Jiang; Shiyuan Fang; Jinxing Li; Qing Li; Zong You Lv; Wan Sheng Chen
Journal:  Front Plant Sci       Date:  2021-12-23       Impact factor: 5.753

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.